Comparing exercise responses to aerobic plus resistance training between postmenopausal breast cancer survivors undergoing aromatase inhibitor therapy and healthy women

References

• DeSantis CE, Bray F, Ferlay J, et al. International variation in female breast cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev. 2015;24:1495–1506.
   PubMed Web of Science ®Google Scholar
• Hashim D, Boffetta P, La Vecchia C, et al. The global decrease in cancer mortality: trends and disparities. Ann Oncol. 2016;27:926–933.
   PubMed Web of Science ®Google Scholar
• Cuzick J, Sestak I, Baum M, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol. 2010;11:1135–1141.
   PubMed Web of Science ®Google Scholar
• Regan MM, Neven P, Giobbie-Hurder A, et al. Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up. Lancet Oncol. 2011;12:1101–1108.
   PubMed Web of Science ®Google Scholar
• Auyeung TW, Lee SWJ, Leung J, et al. Age-associated decline of muscle mass, grip strength and gait speed: a 4-year longitudinal study of 3018 community-dwelling older Chinese. Geriatr Gerontol Int. 2014;14:76–84.
   Google Scholar
• Servitja S, Martos T, Rodriguez Sanz M, et al. Skeletal adverse effects with aromatase inhibitors in early breast cancer: evidence to date and clinical guidance. Ther Adv Med Oncol. 2015;7:291–296.
   PubMed Web of Science ®Google Scholar
• Dowsett M, Forbes JF, Bradley R, et al. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015;386:1341–1352.
   PubMed Web of Science ®Google Scholar
• Chung C, Lee S, Hwang S, et al. Systematic review of exercise effects on health outcomes in women with breast cancer. Asian Nurs Res (Korean Soc Nurs Sci). 2013;7:149–159.
   PubMed Web of Science ®Google Scholar
• Kirkham AA, Bland KA, Sayyari S, et al. Clinically relevant physical benefits of exercise interventions in breast cancer survivors. Curr Oncol Rep. 2016;18:1–9.
   PubMed Web of Science ®Google Scholar
• Battaglini CL, Mills RC, Phillips BL, et al. Twenty-five years of research on the effects of exercise training in breast cancer survivors: a systematic review of the literature. World J Clin Oncol. 2014;5:177–190.
   PubMedGoogle Scholar
• Winters-Stone KM, Dobek J, Bennett JA, et al. The effect of resistance training on muscle strength and physical function in older, postmenopausal breast cancer survivors: a randomized controlled trial. J Cancer Surviv. 2011;6:189–199.
   PubMed Web of Science ®Google Scholar
• Godoy-Izquierdo D, Guevara NM, Toral MV, et al. Improvements in health-related quality of life, cardio-metabolic health, and fitness in postmenopausal women after a supervised, multicomponent, adapted exercise program in a suited health promotion intervention: a multigroup study. Menopause. 2017;24:938–946.
   PubMed Web of Science ®Google Scholar
• Rossi FE, Diniz TA, Neves LM, et al. The beneficial effects of aerobic and concurrent training on metabolic profile and body composition after detraining: a 1-year follow-up in postmenopausal women. Eur J Clin Nutr. 2017;71:638–645.
   PubMed Web of Science ®Google Scholar
• Courneya KS, Segal RJ, Mackey JR, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. 2007;25:4396–4404.
   PubMed Web of Science ®Google Scholar
• Winters-Stone KM, Dobek J, Nail L, et al. Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial. Breast Cancer Res Treat. 2011;127:447–456.
   PubMed Web of Science ®Google Scholar
• Buffart LM, Galvão DA, Brug J, et al. Evidence-based physical activity guidelines for cancer survivors: current guidelines, knowledge gaps and future research directions. Cancer Treat Rev. 2014;40:327–340.
   Google Scholar
• Schulz SVW, Laszlo R, Otto S, et al. Feasibility and effects of a combined adjuvant high-intensity interval/strength training in breast cancer patients: a single-center pilot study. Disabil Rehabil. 2017;21:1–8.
   Google Scholar
• Irwin ML, Cartmel B, Gross CP, et al. Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. J Clin Oncol. 2014;33:1104–1111.
   PubMed Web of Science ®Google Scholar
• Denysschen CA, Burton H, Ademuyiwa F, et al. Exercise intervention in breast cancer patients with aromatase inhibitor-associated arthralgia: a pilot study. Eur J Cancer Care (Engl). 2014;23:493–501.
   PubMed Web of Science ®Google Scholar
• Hansen KR, Knowlton NS, Thyer AC, et al. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod. 2008; 23:699–708.
   PubMed Web of Science ®Google Scholar
• Bruin JP, Bovenhuis H, van Noord PA, et al. The role of genetic factors in age at natural menopause. Hum Reprod. 2001;16:2014–2018.
   PubMed Web of Science ®Google Scholar
• Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;305:465–493.
   Google Scholar
• Organización Mundial De La Salud. Investigaciones sobre la menopausia en los años noventa[Research on menopause in the nineties]. Genebra: Organización Mundial de la Salud; 1996. Spanish.
   Google Scholar
• Adams GM. Exercise physiology: Laboratory manual. 2nd ed. Dubuque (IA): Brown & Benchmark Publishers; 1994.
   Google Scholar
• Ebbeling C, Ward A, Puleo E, et al. Development of a single-stage submaximal treadmill walking test. Med Sci Sports Exerc. 1991;23:966–973.
   PubMed Web of Science ®Google Scholar
• Rossi FE, Fortaleza AC, Neves LM, et al. Combined training (aerobic plus strength) potentiates a reduction in body fat but demonstrates no difference on the lipid profile in postmenopausal women when compared with aerobic training with a similar training load. J Strength Cond Res. 2016;30:226–234.
   Google Scholar
• Hayes SC, Johansson K, Stout NL, et al. Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer. 2012;118:2237–2249.
   PubMed Web of Science ®Google Scholar
• O’Toole JA, Ferguson CM, Swaroop MN, et al. The impact of breast cancer-related lymphedema on the ability to perform upper extremity activities of daily living. Breast Cancer Res Treat. 2015; 150:381–388.
   PubMed Web of Science ®Google Scholar
• Sagen A, Kaaresen R, Sandvik L, et al. Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures. Arch Phys Med Rehabil. 2014;95:875–881.
   PubMed Web of Science ®Google Scholar
• Lintermans A, Laenen A, Van Calster B, et al. Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up data. Ann Oncol. 2013;24:350–355.
   Google Scholar
• Van Londen G, Perera S, Vujevich K, et al. The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer. Breast Cancer Res Treat. 2011;125:441–446.
   PubMed Web of Science ®Google Scholar
• Klassen O, Schmid ME, Ulrich CM, et al. Muscle strength in breast cancer patients receiving different treatment regimes. J Cachexia Sarcopenia Muscle. 2017; 8:305–316.
   Google Scholar
• Schwartz AL. Cancer. In: Durstine JL, Moore GE, editors. ACSM’s exercise management for persons with chronic diseases and disabilities. Champaign (IL): Human Kinetics; 2003. p. 166–172.
   Google Scholar
• Cantarero-Villanueva I, Fernández-Lao C, Díaz-Rodríguez L, et al. The handgrip strength test as a measure of function in breast cancer survivors. Am J Phys Med Rehabil. 2012;91:774–782.
   PubMed Web of Science ®Google Scholar
• Winters-Stone KM, Bennett JA, Nail L, et al. Strength, physical activity, and age predict fatigue in older breast cancer survivors. Oncol Nurs Forum. 2008;35:815–821.
   PubMed Web of Science ®Google Scholar
• Lintermans A, Van Calster B, Van Hoydonck M, et al. Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesis. Ann Oncol. 2011;22:1763–1769.
   PubMed Web of Science ®Google Scholar
• Rietman JS, Dijkstra PU, Debreczeni R, et al. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil. 2015;26:78–84.
   Google Scholar
• Zhu G, Zhang X, Wang Y, et al. Effects of exercise intervention in breast cancer survivors: a meta-analysis of 33 randomized controlled trails. Onco Targets Ther. 2016; 9:2153–2168.
   Google Scholar
• Thomas GA, Cartme B, Harrigan M, et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity (Silver Spring). 2017;25:346–351.
   PubMed Web of Science ®Google Scholar
• Gaya M, Ashford RFU. Cardiac complications of radiation therapy. J Clin Oncol. 2005;17:153–159.
   Google Scholar
• Ewer MS, Gluck S. A woman’s heart: the impact of adjuvant endocrine therapy on cardiovascular health. Cancer. 2009; 115:1813–1826.
   PubMed Web of Science ®Google Scholar
• Foglietta J, Inno A, Iuliis F, et al. Cardiotoxicity of aromatase inhibitors in breast cancer patients. Clin Breast Cancer. 2016;17:11–17.
   PubMed Web of Science ®Google Scholar
• Drum SN, Klika RJ, Carter SD, et al. A feasibility study related to inactive cancer survivors compared with non-cancer controls during aerobic exercise training. J Sports Sci Med. 2016;15:592–600.
   Google Scholar